136 related articles for article (PubMed ID: 27587565)
1. A comparison of medical records and patient questionnaires as sources for the estimation of costs within research studies and the implications for economic evaluation.
Gillespie P; O'Shea E; Smith SM; Cupples ME; Murphy AW
Fam Pract; 2016 Dec; 33(6):733-739. PubMed ID: 27587565
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of a Home Based Intervention for Secondary Prevention of Readmission with Chronic Heart Disease.
Byrnes J; Carrington M; Chan YK; Pollicino C; Dubrowin N; Stewart S; Scuffham PA
PLoS One; 2015; 10(12):e0144545. PubMed ID: 26657844
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of a Collaborative Care Depression and Anxiety Treatment Program in Patients with Acute Cardiac Illness.
Celano CM; Healy B; Suarez L; Levy DE; Mastromauro C; Januzzi JL; Huffman JC
Value Health; 2016; 19(2):185-91. PubMed ID: 27021752
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness of a Proactive Primary Care Program for Frail Older People: A Cluster-Randomized Controlled Trial.
Bleijenberg N; Drubbel I; Neslo RE; Schuurmans MJ; Ten Dam VH; Numans ME; de Wit GA; de Wit NJ
J Am Med Dir Assoc; 2017 Dec; 18(12):1029-1036.e3. PubMed ID: 28801235
[TBL] [Abstract][Full Text] [Related]
5. Occupational therapy compared with social work assessment for older people. An economic evaluation alongside the CAMELOT randomised controlled trial.
Flood C; Mugford M; Stewart S; Harvey I; Poland F; Lloyd-Smith W
Age Ageing; 2005 Jan; 34(1):47-52. PubMed ID: 15537680
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of involving nurse specialists for adult patients with urinary incontinence in primary care compared to care-as-usual: an economic evaluation alongside a pragmatic randomized controlled trial.
Albers-Heitner CP; Joore MA; Winkens RA; Lagro-Janssen AL; Severens JL; Berghmans LC
Neurourol Urodyn; 2012 Apr; 31(4):526-34. PubMed ID: 22275126
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B).
Reynolds MR; Magnuson EA; Wang K; Lei Y; Vilain K; Walczak J; Kodali SK; Lasala JM; O'Neill WW; Davidson CJ; Smith CR; Leon MB; Cohen DJ;
Circulation; 2012 Mar; 125(9):1102-9. PubMed ID: 22308299
[TBL] [Abstract][Full Text] [Related]
8. Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.
Mittmann N; Au HJ; Tu D; O'Callaghan CJ; Isogai PK; Karapetis CS; Zalcberg JR; Evans WK; Moore MJ; Siddiqui J; Findlay B; Colwell B; Simes J; Gibbs P; Links M; Tebbutt NC; Jonker DJ; ;
J Natl Cancer Inst; 2009 Sep; 101(17):1182-92. PubMed ID: 19666851
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of a randomized trial comparing care models for chronic kidney disease.
Hopkins RB; Garg AX; Levin A; Molzahn A; Rigatto C; Singer J; Soltys G; Soroka S; Parfrey PS; Barrett BJ; Goeree R
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1248-57. PubMed ID: 21617091
[TBL] [Abstract][Full Text] [Related]
10. Incorporating considerations of cost-effectiveness, affordability, and resource implications in guideline development: article 6 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
Hill SR; Olson LG; Falck-Ytter Y; Cruz AA; Atkins D; Baumann M; Jaeschke R; Woitalla T; Schünemann HJ;
Proc Am Thorac Soc; 2012 Dec; 9(5):251-5. PubMed ID: 23256167
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of an extended nutritional intervention in older Australian hospitalized patients: a randomized controlled trial.
Sharma Y; Thompson C; Miller M; Shahi R; Hakendorf P; Horwood C; Kaambwa B
BMC Geriatr; 2018 Feb; 18(1):41. PubMed ID: 29402228
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care.
Turner DA; Paul S; Stone MA; Juarez-Garcia A; Squire I; Khunti K
Heart; 2008 Dec; 94(12):1601-6. PubMed ID: 18450843
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study).
Rubio-Valera M; Beneitez I; Peñarrubia-María MT; Luciano JV; Mendive JM; McCrone P; Knapp M; Sabés-Figuera R; Kocyan K; García-Campayo J; Serrano-Blanco A
BMC Psychiatry; 2015 Mar; 15():63. PubMed ID: 25885818
[TBL] [Abstract][Full Text] [Related]
14. Long-term Cost-effectiveness in the Veterans Affairs Open vs Endovascular Repair Study of Aortic Abdominal Aneurysm: A Randomized Clinical Trial.
Lederle FA; Stroupe KT; Kyriakides TC; Ge L; Freischlag JA;
JAMA Surg; 2016 Dec; 151(12):1139-1144. PubMed ID: 27627802
[TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of a pharmacogenetic test: a trial-based evaluation of TPMT genotyping for azathioprine.
Thompson AJ; Newman WG; Elliott RA; Roberts SA; Tricker K; Payne K
Value Health; 2014; 17(1):22-33. PubMed ID: 24438714
[TBL] [Abstract][Full Text] [Related]
16. Long-term cost effectiveness of cardiac secondary prevention in primary care in the Republic of Ireland and Northern Ireland.
Gillespie P; Murphy E; Smith SM; Cupples ME; Byrne M; Murphy AW
Eur J Health Econ; 2017 Apr; 18(3):321-335. PubMed ID: 26961365
[TBL] [Abstract][Full Text] [Related]
17. Cost-utility of collaborative nurse-led self-management support for primary care patients with anxiety, depressive or somatic symptoms: A cluster-randomized controlled trial (the SMADS trial).
Grochtdreis T; Zimmermann T; Puschmann E; Porzelt S; Dams J; Scherer M; König HH
Int J Nurs Stud; 2018 Apr; 80():67-75. PubMed ID: 29353712
[TBL] [Abstract][Full Text] [Related]
18. A Comparison of Different Approaches for Costing Medication Use in an Economic Evaluation.
Heslin M; Babalola O; Ibrahim F; Stringer D; Scott D; Patel A
Value Health; 2018 Feb; 21(2):185-192. PubMed ID: 29477400
[TBL] [Abstract][Full Text] [Related]
19. The cost-effectiveness of the SPHERE intervention for the secondary prevention of coronary heart disease.
Gillespie P; O'Shea E; Murphy AW; Byrne MC; Byrne M; Smith SM; Cupples ME
Int J Technol Assess Health Care; 2010 Jul; 26(3):263-71. PubMed ID: 20584354
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone for secondary prevention of cardiovascular events: results from the CHARISMA trial.
Chen J; Bhatt DL; Dunn ES; Shi C; Caro JJ; Mahoney EM; Gabriel S; Jackson JD; Topol EJ; Cohen DJ
Value Health; 2009 Sep; 12(6):872-9. PubMed ID: 19490556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
